Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests. Photo by Adobe Stock/HealthDay News ...

Peripheral neuropathy is a known potential side effect ... Nearly 41% of patients treated with platinum-based chemo developed nerve pain, as well as just over 38% of those treated with taxanes ...

Supplements are a popular choice for people with neuropathy, as they can help reduce pain and inflammation, improve nerve function, and promote overall health. However, with so many options on the ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Peripheral neuropathy disrupts the normal functioning of the peripheral nerves, which are the nerves outside the brain and spinal cord, leading to a wide variety of symptoms such as pain, numbness ...

Platinum-based or taxane chemotherapy drugs appear to pose the greatest risk for nerve pain, and lung cancer patients seem to have the highest rates of neuropathy, results show. Chemo drugs kill ...